Editas Medicine, Inc. (EDIT): Price and Financial Metrics
EDIT Price/Volume Stats
| Current price | $1.65 | 52-week high | $6.22 |
| Prev. close | $1.49 | 52-week low | $0.91 |
| Day low | $1.48 | Volume | 1,058,867 |
| Day high | $1.65 | Avg. volume | 3,164,042 |
| 50-day MA | $1.37 | Dividend yield | N/A |
| 200-day MA | $2.29 | Market Cap | 137.99M |
EDIT Stock Price Chart Interactive Chart >
Editas Medicine, Inc. (EDIT) Company Bio
Editas Medicine Inc. operates as a genome editing company. It focuses on translating its genome editing technology into a class of human therapeutics that enable precise and corrective molecular modification to treat the underlying cause of a range of diseases at the genetic level. Editas Medicine Inc. was formerly known as Gengine, Inc. and changed its name to Editas Medicine Inc. in November 2013. The company was founded in 2013 and is based in Cambridge, Massachusetts.
EDIT Price Returns
| 1-mo | N/A |
| 3-mo | -48.44% |
| 6-mo | -30.38% |
| 1-year | -70.11% |
| 3-year | -85.03% |
| 5-year | -94.36% |
| YTD | 29.92% |
| 2024 | -87.46% |
| 2023 | 14.21% |
| 2022 | -66.59% |
| 2021 | -62.13% |
| 2020 | 136.78% |
Continue Researching EDIT
Want to do more research on Editas Medicine Inc's stock and its price? Try the links below:Editas Medicine Inc (EDIT) Stock Price | Nasdaq
Editas Medicine Inc (EDIT) Stock Quote, History and News - Yahoo Finance
Editas Medicine Inc (EDIT) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...